Journal of Nuclear Medicine

The new JNM Supplement is online now – “Molecular Imaging of Neurodegeneration: The Way to New Horizons”

Radiolabeled GPVI-Fc for PET Imaging of Multiple Extracellular Matrix Fibers: A New Look into Pulmonary Fibrosis Progression
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
18F-FDG PET/CT in the Management of Osteosarcoma
Future Directions in Molecular Imaging of Neurodegenerative Disorders

Published Ahead of Print

You have access
Metformin-Induced Receptor Turnover Alters Antibody Accumulation in HER-Expressing Tumors
Sandeep Surendra Panikar, Nai Keltee, Na-Keysha Berry, Shayla Shmuel, Zachary T. Fisher, Emma Brown, Abbey Zidel, Alex Mabry and Patrícia M.R. Pereira

Journal of Nuclear Medicine June 2, 2023, jnumed.122.265248; DOI: https://doi.org/10.2967/jnumed.122.265248
Open Access
Initial Evaluation of [¹⁸F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
Tadashi Watabe, Sadahiro Naka, Mitsuaki Tatsumi, Takashi Kamiya, Toru Kimura, Yasushi Shintani, Kaori Abe, Tomohiro Miyake, Kenzo Shimazu, Shogo Kobayashi, Yukinori Kurokawa, Hidetoshi Eguchi, Yuichiro Doki, Hidenori Inohara, Hiroki Kato, Yuriko Mori, Jens Cardinale and Frederik L. Giesel

Journal of Nuclear Medicine June 2, 2023, jnumed.123.265486; DOI: https://doi.org/10.2967/jnumed.123.265486
You have access
MIRD Pamphlet No. 28, Part 2: Comparative Evaluation of MIRDcalc Dosimetry Software Across a Compendium of Diagnostic Radiopharmaceuticals
Lukas M. Carter, Juan C. Ocampo Ramos, Edmond A. Olguin, Justin L. Brown, Daniel Lafontaine, Derek W. Jokisch, Wesley E. Bolch and Adam L. Kesner

Journal of Nuclear Medicine June 2, 2023, jnumed.122.264230; DOI: https://doi.org/10.2967/jnumed.122.264230
Open Access
Optimized SPECT Imaging of ²²⁴Ra α-Particle Therapy by ²¹²Pb Photon Emissions
Lars Tore Gyland Mikalsen, Monika Kvassheim and Caroline Stokke

Journal of Nuclear Medicine June 2, 2023, jnumed.122.264455; DOI: https://doi.org/10.2967/jnumed.122.264455
You have access
MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
Adam L. Kesner, Lukas M. Carter, Juan C. Ocampo Ramos, Daniel Lafontaine, Edmond A. Olguin, Justin L. Brown, Bonnie President, Derek W. Jokisch, Darrell R. Fisher and Wesley E. Bolch

Journal of Nuclear Medicine June 2, 2023, jnumed.122.264225; DOI: https://doi.org/10.2967/jnumed.122.264225
You have access
Fibroblast Activation Protein Inhibitor–Based Radionuclide Therapies: Current Status and Future Directions
Manish Ora, Neetu Soni, Aftab Hasan Nazar, Manish Dixit, Rohit Singh, Savita Puri, Michael M. Graham and Sanjay Gambhir

Journal of Nuclear Medicine June 2, 2023, jnumed.123.265594; DOI: https://doi.org/10.2967/jnumed.123.265594

Featured Articles

Radiolabeled GPVI-Fc for PET Imaging of Multiple Extracellular Matrix Fibers: A New Look into...

June 01, 2023
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer

June 01, 2023
¹⁸F-FDG PET/CT in the Management of Osteosarcoma

June 01, 2023
¹⁸F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for...

June 01, 2023
Artificial Intelligence Algorithms Need to Be Explainable—or Do They?

June 01, 2023
Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine

June 01, 2023
Defining Myeloma and Advancing Treatment Options

June 01, 2023

About The Journal of Nuclear Medicine

The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research.